🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study

Recruitingn/aAges 18 Years - anyAllAbdulkadir Küçük
NCT07821450 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Intravitreal anti-VEGF injections are a mainstay of treatment for retinal diseases such as neovascular age-related macular degeneration, diabetic macular edema and retinal vein occlusion, and usually require repeated administration over years. During each injection an eyelid speculum holds the lids open and the upper eyelid is exposed to repeated mechanical stretch. Aponeurotic ptosis after intraocular surgery is well described, but evidence on blepharoptosis after repeated intravitreal injections is limited and conflicting. This single-center prospective observational study enrolls 60 patients who are starting intravitreal anti-VEGF therapy in one eye only; the untreated fellow eye of each patient serves as an internal control. Upper eyelid position and function are assessed with margin reflex distance-1 (MRD-1), margin reflex distance-2 (MRD-2) and levator function at baseline and at

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older * Planned initiation of intravitreal anti-VEGF injection in one eye only for a retinal disease * No prior intravitreal injection in either eye * Able to attend the scheduled follow-up visits and to cooperate for the duration of the study * Reliable MRD-1, MRD-2 and levator function measurement possible in both eyes (clear corneal light reflex, clearly visible eyelid margin, able to maintain primary gaze) * Signed informed consent Exclusion Criteria: * Pre-existing blepharoptosis or significant eyelid malposition at the baseline examination * Previous ptosis surgery, blepharoplasty or other eyelid surgery that may affect upper eyelid anatomy * History of myasthenia gravis, oculomotor nerve palsy, Horner syndrome, facial nerve palsy or a similar neurologic or neuromuscular disorder * History of orbital trauma, orbital surgery or orbital disease * Advanced dermatochalasis, eyelid retraction, entropion, ectropion or marked facial asymmetry precluding reliable eyelid measurement * Need for intravitreal injection in both eyes during the study period * Ocular or periocular surgery during follow-up that may affect upper eyelid position * Inability to comply with follow-up visits or incomplete measurements * Withdrawal of consent * Inability to obtain reliable eyelid measurements due to severe blepharospasm, advanced corneal opacity, marked eyelid edema, or inability to maintain head or neck position or to cooperate
💊

What it tests

  • Repeated intravitreal anti-VEGF injection with eyelid speculum
📍

Where

1 site
University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy